Neurology News

The FDA announced the approval of Vyvgart for treatment of the chronic autoimmune, neuromuscular disease myasthenia gravis in adults who are positive for acetylcholine receptor antibody.

Rapid intensive care, including endovascular therapy after stroke, proved to be a factor in less memory loss, according to results of a survey published in the American Academy of Neurology.

Although rituximab was safe and well tolerated in acetylcholine receptor antibody-positive generalized myasthenia gravis, researchers noted low probability of it significantly reducing steroid use at 1 year.

Despite a slight decrease in the worldwide incidence and mortality rates for stroke between 1990 and 2019, the overall numbers remain high, according to study results published in Neurology.

Health care spending in the United States increased 9.7% from 2019, reaching $4.1 trillion in 2020, or $12,530 per person, according to CMS.

Physical activity and air pollution correlated with positive and negative brain outcomes, respectively, according to study results published in Neurology.

A new classification system accurately predicted which patients with ischemic stroke of unknown original might benefit from patent foramen ovale closure.

A recent report identified potential gaps in care among younger generations and barriers to patient data, both of which can lead to suboptimal health outcomes, an expert said.

In-person clinic visits were shorter when clinicians explicitly responded to patients’ emotional expressions, according to an observational analysis published in Annals of Family Medicine.

A validated score was able to predict among which patients with epilepsy stereoelectroencephalography was unlikely to identify a focal seizure-onset zone, according to results of a cohort study published in JAMA Neurology.